Atara Biotherapeutics (ATRA) Reports Q4 Loss, Lags Revenue Estimates
28/2 23:55
Atara Biotherapeutics (ATRA) came out with a quarterly loss of $0.96 per share versus the Zacks Consensus Estimate of a loss of $0.60. This compares to loss of $0.95 per share a year ago. These figures are adjusted for non-recurring items....